Belviq Lawsuits For Pancreatic Cancer, Colon Cancer, Rectal Cancer, Lung Cancer
In a rush? You can use our Quick Contact Form to tell us the basic information about your case.
In February 2020 there was a Belviq recall due to cancer cases observed in a Belviq safety clinical trial. The Belviq FDA Drug Safety Communication announcing this Belviq recall, “FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market”, noted that excess cases of pancreatic cancer, colon cancer, rectal cancer, and lung cancer were observed. This Belviq recall has resulted in Belviq lawsuits being filed against the responsible pharmaceutical company, Eisai Inc.
The Data Summary section of the Belviq FDA Drug Safety Communication set forth these findings from the Belviq safety clinical trial:
Imbalances in specific cancers including pancreatic, colorectal, and lung contributed to the observed overall imbalance in cancer cases. There was no apparent difference in the incidence of cancer over the initial months of treatment, but the imbalance increased with longer duration on [Belviq (lorcaserin)].
According to the FDA, these are some of the specific types of cancer associated with Belviq:
- Pancreatic Cancer
- Colorectal Cancer
- Colon Cancer
- Rectal Cancer
- Lung Cancer
Our law firm is investigating possible Belviq lawsuits where patients have been diagnosed with cancer, including but not limited to the types listed above.
Free Belviq Lawsuits Case Evaluation
We encourage you to submit a Belviq Lawsuits Case Evaluation Form online – it is free, confidential, and there is no obligation. Or, if you prefer, call our toll-free number, (800) 426-9535, to speak directly to attorney Tom Lamb about a possible drug injury case. Either way, you will get Mr. Lamb’s impressions — not an intake person, a paralegal, nor some other lawyer — about your case based on his many years of experience.
Most Recent Article About Belviq
There Will Be No Belviq Generic Drugs After Belviq Drug Recall in 2020
There has been some further FDA action regarding Belviq which is related to the 2020 Belviq drug recall that was due to an increased risk of cancer. This further FDA action means there will be no Belviq generic drugs after the Belviq drug recall in 2020.
This February 26, 2021 Notice item, “Determination That BELVIQ (Lorcaserin Hydrochloride) Tablets, 10 Milligrams, and BELVIQ XR (Lorcaserin Hydrochloride) Extended-Release Tablets, 20 Milligrams, Were Withdrawn From Sale for Reasons of Safety or Effectiveness” appeared in the March 4, 2021 edition of the Federal Register.
To read more of this article, click below:
From the Summary section of that 2021 Federal Register Notice:
The Food and Drug Administration (FDA or Agency) has determined that BELVIQ (lorcaserin hydrochloride) tablets, 10 milligrams (mg), and BELVIQ XR (lorcaserin hydrochloride) extended-release tablets, 20 mg, were withdrawn from sale for reasons of safety or effectiveness. The Agency will not accept or approve abbreviated new drug applications (ANDAs) for lorcaserin hydrochloride tablets, 10 mg and 20 mg.
According to that 2021 Federal Register Notice, this further FDA action regarding Belviq means:
[The FDA] will remove BELVIQ (lorcaserin hydrochloride) tablets, 10 mg, and BELVIQ XR (lorcaserin hydrochloride) extended-release tablets, 20 mg, from the list of drug products published in the Orange Book. FDA will not accept or approve ANDAs that refer to this drug product.
Going back to the February 2020 FDA Drug Safety Communication announcing the Belviq drug recall, “FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market”, these are some of the specific types of cancer associated with Belviq:
Pancreatic Cancer
Colorectal Cancer
Colon Cancer
Rectal Cancer
Lung Cancer
Our law firm is investigating possible Belviq lawsuits where patients have been diagnosed with cancer, including but not limited to the types listed above.
[Read article in full at original source]Earlier articles about Belviq by attorney Tom Lamb on the Side Effects Blog:
- FDA Belviq Recall Decision Came After Safety Data Review Found Excess Cancers Risks
- After Drug Recall Belviq Lawsuits Alleging Failure To Warn About Cancer
- Belviq Recall Due To Certain Cancers: Pancreatic, Colon, Rectal, And Lung
- Weight-Loss Medicine Belviq Increased Risk Of Cancers Says FDA Drug Safety Communication